Royal Cargo, the Philippines’ leading specialized logistics provider, was granted a License to Operate as a Drug Manufacturer by the Food and Drug Administration for its South Hub facility, enabling it to offer essential value-added services such as repacking and labeling
In a statement, Royal Cargo said the new license allows Royal Cargo to provide specialized repacking and packaging services for medical equipment and devices, ensuring quality, compliance, and efficiency in handling critical healthcare products.
On January 16, 2025, the South Hub was granted the license to operate a Drug Manufacturer. This empowers pharmaceutical and cosmetics companies to meet stringent regulatory and market-specific packaging requirements efficiently.
On October 9, 2024, the South Hub facility also secured a License to Operate as a Medical Devices Manufacturer.
It dual license to operate solidifies the South Hub’s pivotal role in pharmaceutical and medical device sectors logistics.
These dual FDA approvals position Royal Cargo South Hub as a comprehensive healthcare logistics hub, ready to support the industry’s evolving demands. With its specialized infrastructure and services, and the upcoming “Medical and Logistics Solutions Ecozone,” Royal Cargo is poised to drive growth and streamline the healthcare supply chain for its partners.
